Literature DB >> 29128352

Scavenger receptor class B type 1 regulates neuroblastoma cell proliferation, migration and invasion.

Marlyn Panchoo1, Andras Lacko2.   

Abstract

Neuroblastoma (NB) is an extra cranial pediatric embryonal tumor most prevalent in children less than 1 year of age. NB accounts for 7% of all pediatric cancers but accounts for 15% of all childhood cancer deaths. Scavenger receptor class B type 1 (SR-B1), a mediator of cellular cholesterol uptake, is overexpressed in and have been linked to the aggressiveness of many cancers. Nevertheless, no studies have so far investigated the relationship between SR-B1 and NB. Elucidation of receptors that promote NB may pave the way for discovery of new therapeutic targets. Here we show that inhibition of SR-B1 reduced cell survival, migration and invasion, and cholesterol content in NB cell lines. Additionally analysis of SR-B1 levels in NB patient biopsies using the R2: Genomics Analysis and Visualization Platform showed that high SR-B1 expression correlated with decreased overall and event-free survival.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cholesterol metabolism; Neuroblastoma; Scavenger receptor class B type 1

Mesh:

Substances:

Year:  2017        PMID: 29128352     DOI: 10.1016/j.bbrc.2017.10.154

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

Review 1.  Surface-modified nanotherapeutics targeting atherosclerosis.

Authors:  Wenpan Li; Karina Marie Gonzalez; Jinha Chung; Minhyeok Kim; Jianqin Lu
Journal:  Biomater Sci       Date:  2022-09-27       Impact factor: 7.590

2.  The SR-B1 Receptor as a Potential Target for Treating Glioblastoma.

Authors:  Ethan Berney; Nirupama Sabnis; Marlyn Panchoo; Sangram Raut; Rob Dickerman; Andras G Lacko
Journal:  J Oncol       Date:  2019-06-03       Impact factor: 4.375

3.  27-Hydroxycholesterol Promotes the Transfer of Astrocyte-Derived Cholesterol to Neurons in Co-cultured SH-SY5Y Cells and C6 Cells.

Authors:  Yushan Wang; Xiaona Zhang; Tao Wang; Wen Liu; Lijing Wang; Ling Hao; Mengwei Ju; Rong Xiao
Journal:  Front Cell Dev Biol       Date:  2020-11-24

Review 4.  Reconstituted HDL: Drug Delivery Platform for Overcoming Biological Barriers to Cancer Therapy.

Authors:  Sangram Raut; Linda Mooberry; Nirupama Sabnis; Ashwini Garud; Akpedje Serena Dossou; Andras Lacko
Journal:  Front Pharmacol       Date:  2018-10-15       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.